Healthcare provider profile · identity verified

Susan Lanser, MD

Family Practice · MC BAIN, MI · NPI 1740280965

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	680	174
Levothyroxine Sodium	Levothyroxine Sodium	378	91
Lisinopril	Lisinopril	351	95
Losartan Potassium	Losartan Potassium	295	86
Amlodipine Besylate	Amlodipine Besylate	285	78
Omeprazole	Omeprazole	262	73
Metoprolol Succinate	Metoprolol Succinate	245	70
Hydrochlorothiazide	Hydrochlorothiazide	179	45
Duloxetine Hcl	Duloxetine Hcl	178	37
Gabapentin	Gabapentin	155	25
Sertraline Hcl	Sertraline Hcl	149	28
Metformin Hcl	Metformin Hcl	126	29
Escitalopram Oxalate	Escitalopram Oxalate	118	30
Meloxicam	Meloxicam	114	26
Simvastatin	Simvastatin	110	29
Eliquis	Apixaban	105	26
Metoprolol Tartrate	Metoprolol Tartrate	101	25
Albuterol Sulfate Hfa	Albuterol Sulfate	99	42
Pravastatin Sodium	Pravastatin Sodium	99	27
Furosemide	Furosemide	96	26
Famotidine	Famotidine	95	32
Metformin Hcl Er	Metformin Hcl	95	21
Buspirone Hcl	Buspirone Hcl	91	20
Pantoprazole Sodium	Pantoprazole Sodium	87	19
Mounjaro	Tirzepatide	80	12
Clopidogrel	Clopidogrel Bisulfate	79	16
Trazodone Hcl	Trazodone Hcl	79	18
Potassium Chloride	Potassium Chloride	75	16
Alendronate Sodium	Alendronate Sodium	73	22
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	73	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	69	19
Prednisone	Prednisone	68	46
Spironolactone	Spironolactone	65	18
Jardiance	Empagliflozin	61	12
Bisoprolol Fumarate	Bisoprolol Fumarate	58	14
Doxycycline Hyclate	Doxycycline Hyclate	57	51
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	11
Oxybutynin Chloride Er	Oxybutynin Chloride	54	12
Allopurinol	Allopurinol	53	16
Atenolol	Atenolol	49	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	12
Bumetanide	Bumetanide	48	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	46	17
Fluticasone Propionate	Fluticasone Propionate	45	17
Tramadol Hcl	Tramadol Hcl	41	suppressed
Januvia	Sitagliptin Phosphate	40	suppressed
Carvedilol	Carvedilol	38	13
Cephalexin	Cephalexin	33	20
Montelukast Sodium	Montelukast Sodium	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Alprazolam	Alprazolam	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	11
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Ozempic	Semaglutide	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	11
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	24	suppressed
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Loperamide	Loperamide Hcl	23	suppressed
Lurasidone Hcl	Lurasidone Hcl	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Rivastigmine	Rivastigmine	22	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Cilostazol	Cilostazol	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Pen Needles	Pen Needle, Diabetic	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	15
Trulicity	Dulaglutide	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Verapamil Hcl	Verapamil Hcl	15	suppressed
Calcitriol	Calcitriol	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Acebutolol Hcl	Acebutolol Hcl	12	suppressed
Acyclovir	Acyclovir	12	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Lorazepam	Lorazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error